Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 10 matching records.
10 results — page 1 of 1
- Level DNarrative ReviewPubMed
Regenerative medicine and tissue engineering potential of mesenchymal stem cells exosomes-derived microRNAs.
Narrative Review on Tendon Injury, Chronic Wound, Autoimmune Research, published in Differentiation (2025) — summary generated from the PubMed abstract.
- 2025
Differentiation - Level DNarrative ReviewEurope PMC
Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment
Narrative Review on Neuroinflammation, Autoimmune Research, published in Cell Mol Neurobiol (2024) — summary generated from the PubMed abstract.
- 2024
Cell Mol Neurobiol4 citations - Level DLaboratory StudyEurope PMC
Targeting Metabolic Syndrome Pathways: Carrot microRNAs As Potential Modulators
Laboratory Study on Type 2 Diabetes, published in ACS Omega (2024) — summary generated from the PubMed abstract.
- 2024
ACS Omega2 citations - Level DNarrative ReviewPubMed
MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential.
Narrative Review on Type 2 Diabetes, Cardiovascular Disease, published in Genes Dis (2024) — summary generated from the PubMed abstract.
- 2024
Genes Dis - Level ASystematic ReviewEurope PMC
Prognostic and therapeutic potential of microRNAs for fracture healing processes and non-union fractures: A systematic review
Systematic Review, published in Clin Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
Clin Transl Med27 citations - Level CProspective StudyEurope PMC
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Prospective Study with a reported sample of 63 on Type 2 Diabetes, published in Cardiovasc Diabetol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 63
Cardiovasc Diabetol21 citations - Level DNarrative ReviewPubMed
Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
Narrative Review on Chronic Kidney Disease, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther38 citations - Level BClinical TrialEurope PMC
Dysfunction of the Neurovascular Unit in Ischemic Stroke: Highlights on microRNAs and Exosomes as Potential Biomarkers and Therapy
Clinical Trial on Stroke Research, published in Int J Mol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Int J Mol Sci38 citations - Level DNarrative ReviewEurope PMC
MicroRNAs as Potential Regulators of Glutathione Peroxidases Expression and Their Role in Obesity and Related Pathologies
Narrative Review on Systemic / IV, published in Int J Mol Sci (2018) — summary generated from the PubMed abstract.
- 2018
Int J Mol Sci49 citations - Level DNarrative ReviewEurope PMC
The Potential of microRNAs for Stem Cell-based Therapy for Degenerative Skeletal Diseases
Narrative Review on Osteoarthritis, Cartilage Damage, published in Curr Mol Biol Rep (2017) — summary generated from the PubMed abstract.
- 2017
Curr Mol Biol Rep13 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406